Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

DNA Mismatch Repair Gene Variants in Sporadic Solid Cancers

F. Caja, L. Vodickova, J. Kral, V. Vymetalkova, A. Naccarati, P. Vodicka

. 2020 ; 21 (15) : . [pub] 20200803

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012289

Grantová podpora
18-09709S and 19-10543S Grantová Agentura České Republiky
NV18-00199 Agentura Pro Zdravotnický Výzkum České Republiky
61388971 (CZ) Institutional Grant RVO
UNCE/MED/006; Univerzita Karlova v Praze
Progres Q28 Univerzita Karlova v Praze
(NPU I) Nr. LO1503 Ministerstvo Školství, Mládeže a Tělovýchovy

The phenotypic effects of single nucleotide polymorphisms (SNPs) in the development of sporadic solid cancers are still scarce. The aim of this review was to summarise and analyse published data on the associations between SNPs in mismatch repair genes and various cancers. The mismatch repair system plays a unique role in the control of the genetic integrity and it is often inactivated (germline and somatic mutations and hypermethylation) in cancer patients. Here, we focused on germline variants in mismatch repair genes and found the outcomes rather controversial: some SNPs are sometimes ascribed as protective, while other studies reported their pathological effects. Regarding the complexity of cancer as one disease, we attempted to ascertain if particular polymorphisms exert the effect in the same direction in the development and treatment of different malignancies, although it is still not straightforward to conclude whether polymorphisms always play a clear positive role or a negative one. Most recent and robust genome-wide studies suggest that risk of cancer is modulated by variants in mismatch repair genes, for example in colorectal cancer. Our study shows that rs1800734 in MLH1 or rs2303428 in MSH2 may influence the development of different malignancies. The lack of functional studies on many DNA mismatch repair SNPs as well as their interactions are not explored yet. Notably, the concerted action of more variants in one individual may be protective or harmful. Further, complex interactions of DNA mismatch repair variations with both the environment and microenvironment in the cancer pathogenesis will deserve further attention.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012289
003      
CZ-PrNML
005      
20210713151511.0
007      
ta
008      
210420s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ijms21155561 $2 doi
035    __
$a (PubMed)32756484
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Caja, Fabian $u Department of Immunotherapy, Institute of Microbiology of the Czech Academy of Sciences, 14200 Prague, Czech Republic ; Department of Cell Biology, Faculty of Science, Charles University, 12000 Prague, Czech Republic
245    10
$a DNA Mismatch Repair Gene Variants in Sporadic Solid Cancers / $c F. Caja, L. Vodickova, J. Kral, V. Vymetalkova, A. Naccarati, P. Vodicka
520    9_
$a The phenotypic effects of single nucleotide polymorphisms (SNPs) in the development of sporadic solid cancers are still scarce. The aim of this review was to summarise and analyse published data on the associations between SNPs in mismatch repair genes and various cancers. The mismatch repair system plays a unique role in the control of the genetic integrity and it is often inactivated (germline and somatic mutations and hypermethylation) in cancer patients. Here, we focused on germline variants in mismatch repair genes and found the outcomes rather controversial: some SNPs are sometimes ascribed as protective, while other studies reported their pathological effects. Regarding the complexity of cancer as one disease, we attempted to ascertain if particular polymorphisms exert the effect in the same direction in the development and treatment of different malignancies, although it is still not straightforward to conclude whether polymorphisms always play a clear positive role or a negative one. Most recent and robust genome-wide studies suggest that risk of cancer is modulated by variants in mismatch repair genes, for example in colorectal cancer. Our study shows that rs1800734 in MLH1 or rs2303428 in MSH2 may influence the development of different malignancies. The lack of functional studies on many DNA mismatch repair SNPs as well as their interactions are not explored yet. Notably, the concerted action of more variants in one individual may be protective or harmful. Further, complex interactions of DNA mismatch repair variations with both the environment and microenvironment in the cancer pathogenesis will deserve further attention.
650    _2
$a metylace DNA $x genetika $7 D019175
650    _2
$a oprava chybného párování bází DNA $x genetika $7 D053843
650    _2
$a progrese nemoci $7 D018450
650    _2
$a zárodečné mutace $x genetika $7 D018095
650    _2
$a lidé $7 D006801
650    _2
$a MutL homolog 1 $x genetika $7 D000070957
650    _2
$a homolog 2 proteinu MutS $x genetika $7 D051718
650    _2
$a nádory $x genetika $x patologie $7 D009369
650    _2
$a jednonukleotidový polymorfismus $x genetika $7 D020641
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Vodickova, Ludmila $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, 14220 Prague, Czech Republic ; Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, 12000 Prague, Czech Republic ; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, 32300 Pilsen, Czech Republic
700    1_
$a Kral, Jan $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, 14220 Prague, Czech Republic ; Department of Gastroenterology and Hepatology, Institute for Clinical and Experimental Medicine, 14200 Prague, Czech Republic
700    1_
$a Vymetalkova, Veronika $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, 14220 Prague, Czech Republic ; Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, 12000 Prague, Czech Republic ; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, 32300 Pilsen, Czech Republic
700    1_
$a Naccarati, Alessio $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, 14220 Prague, Czech Republic ; Italian Institute for Genomic Medicine (IIGM), 10060 Torino, Italy
700    1_
$a Vodicka, Pavel $u Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, 14220 Prague, Czech Republic ; Institute of Biology and Medical Genetics, 1st Medical Faculty, Charles University, 12000 Prague, Czech Republic ; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, 32300 Pilsen, Czech Republic
773    0_
$w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 15 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32756484 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210713151508 $b ABA008
999    __
$a ok $b bmc $g 1650619 $s 1132668
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 15 $e 20200803 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
GRA    __
$a 18-09709S and 19-10543S $p Grantová Agentura České Republiky
GRA    __
$a NV18-00199 $p Agentura Pro Zdravotnický Výzkum České Republiky
GRA    __
$a 61388971 (CZ) $p Institutional Grant RVO
GRA    __
$a UNCE/MED/006; $p Univerzita Karlova v Praze
GRA    __
$a Progres Q28 $p Univerzita Karlova v Praze
GRA    __
$a (NPU I) Nr. LO1503 $p Ministerstvo Školství, Mládeže a Tělovýchovy
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace